5-Fluorouracil (NSC-19893) compared to cyclophosphamide (NSC-26271) in bronchogenic carcinoma: results of a clinical study
Brugarolas, A.; Rivas, A.; Lacave, A.J.; Gonzalez-Palacois, F.; Froufe, A.
Cancer ChemoTherapy Reports 59(5): 1025-1026
1975
ISSN/ISBN: 0069-0112 PMID: 1106844 Document Number: 84597
Document emailed within 1 workday
Related Documents
Taguchi, T.; Sakai, K.; Terasawa, T.; Wada, H. 1986: Results of clinical trials with a CMitF (cyclophosphamide, mitoxantrone, and 5-fluorouracil) regimen versus a CAF (cyclophosphamide, adriamycin, and 5-fluorouracil) regimen in advanced/relapsed breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(9): 2820-2828Kochnowski, G.; Rozek, G.; Wisńiewski, J. 1976: Early results of bronchogenic carcinoma treatment with massive doses of cyclophosphamide Wiadomosci Lekarskie 29(4): 270-271
Pisoni, M.B.; Libretti, A.; Piazza, E.; Vago, G.; Scapaticci, R.; Bianchi, C.; Tomirotti, M.; Scanni, A.; Calzavara, M.P.; Cassani, L.; Scarpazza, G.; Marsoni, S.; Morasca, L. 1981: Phase Ii study of cyclophosphamide and hexamethylmelamine in non-oat cell bronchogenic carcinoma Cancer Treatment Reports 65(7-8): 731-732
Vogelzang, N.J.; Bonomi, P.D.; Rossof, A.H.; Wolter, J. 1978: Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP) treatment of non-oat cell bronchogenic carcinoma Cancer Treatment Reports 62(10): 1595-1597
Piver, M.S.; Barlow, J.J.; Dunbar, J. 1980: Doxorubicin, cyclophosphamide, and 5-fluorouracil in patients with carcinoma of the cervix or vagina Cancer Treatment Reports 64(4-5): 549-551
Nowak, C.; Arnold, W.; Henneberger, G.; Tanneberger, S. 1980: Therapeutic effectiveness of carminomycin (CRM) in combination with dibromodulcitol (DBD) compared with the combination vincristine, cyclophosphamide, methotrexate, 5-fluorouracil (VCMF) on some tumor systems Archiv für Geschwulstforschung 50(8): 747-757
Samson, M.K.; Baker, L.H.; Fraile, R.J.; Izbicki, R.M.; Vaitkevicius, V.K. 1977: Combination chemotherapy with cyclophosphamide, vincristine, methyl-CCNU, and bleomycin in advanced bronchogenic carcinoma: experience with 106 patients Cancer Treatment Reports 61(1): 59-64
Sismondi, P.; Zola, P.; Galletto, L.; De Giovanni, D.; Giardina, G. 1979: Evaluation of the toxicity of precautional chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in carcinoma of the breast in the first 700 treatment cycles Minerva Ginecologica 31(7-8): 563-568
Trouillas, P.; Neuschwander, P.; Nighoghossian, N.; Adeleine, P.; Tremisi, P. 1989: Intensive immunosuppression in progressive multiple sclerosis. An open study comparing 3 groups: cyclophosphamide, cyclophosphamide-plasmapheresis and control subjects. Results after 3 years Revue Neurologique (Paris) 145(5): 369-377
Hiddemann, W.; Ruelfs, C.; Ottensmeier, C.; Rückle, H.; Musch, E.; Koch, O.; van de Loo, J. 1992: Interleukin-2 followed by fluorouracil and folinic acid in refractory colorectal cancer--results of a clinical phase Ii study Seminars in Oncology 19(2 Suppl 3: 225-227
Klaassen, U.; Harstrick, A.; Wilke, H.; Seeber, S. 1996: Preclinical and clinical study results of the combination of paclitaxel and 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer Seminars in Oncology 23(1 Suppl 1: 44-47
Mostecký, H.; Melínová, L.; Zámecník, J. 1980: Results of combined treatment of small-cell bronchogenic carcinoma Vnitrni Lekarstvi 26(1): 71-76
Denck, H. 1978: How could the results of surgical treatment of bronchogenic carcinoma be improved? (authors transl) Wiener Klinische Wochenschrift 90(8): 275-283
Krause, F. 1977: Long-term results of surgery of bronchogenic squamous cell carcinoma Praxis und Klinik der Pneumologie 31(4): 202-207
Forni, E.; Volpato, G.; Meriggi, F.; Rossi, G.; Bordoni, P.; Clerico, D.; Lo Monaco, G.; Spelzini, P.; Stradiotti, G.; Zadra, F. 1989: Bronchogenic carcinoma invading the thoracic wall. The results of surgical treatment Minerva Medica 80(7): 679-683
Fiala, P.; Cermák, J.; Kubík, A. 1997: Results of resection of a stage IIIA/N2 non-small cell bronchogenic carcinoma Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 76(2): 80-84
Misset, J.L.; Metz, R.; Gil-Delgado, M.; Keiling, R.; Cappelaere, P.; Armand, J.P.; Prévot, G.; Grimbert, J.; Mathé, G.; Hibberd, M. 1987: Mitoxantrone combined with vincristine, cyclophosphamide and fluorouracil for advanced breast cancer. a study of short-term response rate Anticancer Research 7(4b): 737-740
Morabito, G.; Rainer, E. 1984: Results of a controlled clinical trial of Corti-fluoral compared to placebo. a double-blind study Minerva Stomatologica 33(5): 875-880
Naganuma, A.; Toyoda, M.; Hamada, T.; Hagiwara, S.; Yanagisawa, M.; Kosone, T.; Arai, H.; Abe, T.; Takagi, H. 2007: Clinical study of low-dose cisplatin and 5-fluorouracil chemotherapy via implanted fusion port in 20 patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(5): 729-734
Sosovec, V.; Stopek, D. 1972: Diabetes insipidus as a 1st clinical manifestation of inconspicuous bronchogenic carcinoma Vnitrni Lekarstvi 18(8): 806-810